Back to mobile site

DepoMed, Inc. (DEPO) Tops Q2 EPS by 7c

August 6, 2014 4:10 PM EDT

DepoMed, Inc. (NASDAQ: DEPO) reported Q2 EPS of ($0.01), $0.07 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $67.7 million versus the consensus estimate of $38.03 million.

For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings